A molecular modelling study was carried out in order to compare the structural and electronic properties of the pyridinone L-696,229 and the HEPT derivative EBPU. This comparison led to a hybrid structure, 3-(benzyloxymethyl)-5-ethyl-6-methylpyridin-2-one [18a], which revealed a good structural correlation with the models. A series of 2-[(arylmethyl)oxymethyl]pyridin-2-ones related to [18a] was synthesized and tested for antiviral activity against human immunodeficiency virus type 1 (HIV-1). Compound [18a] and four other derivatives showed anti-HIV-1 activity.
ChouJ & ChouTC (1985) Dose-effect analysis with microcomputers: quantitation of ED50, LD50, synergism, antagonism, low-dose risk, receptor binding and enzyme kinetics. Computer software for Apple II Series and IBM-PC and instruction manual. Cambridge: Elsevier-Biosoft, pp. 19–28.
2.
ClarkMCramerRDIII & van OpdenboshN (1989) Validation of the general purpose Tripos 5.2 force field. Journal of Computational Chemistry10: 982–1012.
3.
ClarkMCramerRDIIIJonesDMPattersonDE & SimperathPE (1990) Comparative molecular field analysis. 2. Toward its use with 3D structural databases. Tetrahedron Computer Methodology3:47.
4.
CramerRDIIIPattersonDE & BrunceJD (1988) Comparative molecular field analysis. 1. Effect of shape on binding of steroids to proteins. Journal of the American Chemical Society110:5959.
5.
DebyserZPauwelsRAndriesKDesmyterJKuklaMJanssenPAJ & De ClercqE (1991) An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo[4,5,1-jk] [1,4] benzodiazepin-2 (1H)-one and thione derivatives. Proceedings of the National Academy of Sciences, USA88:1451–1455.
6.
DournonEMathesonSRosenbaumWGhanakhanianSMichowCGirardPMPezzonneCSalmonDDe TruchioPLepostCBouvetEDazzaMCle VacherMRegnierB & the Claude Bernard Hospital AZT Study Group (1988) Effects of zidovudine in 365 consecutive patients with AIDS or AIDS related complex. Lanceti: 1297–1302.
7.
GasteigerJ & MarsiliM (1980) Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron36: 3219–3228.
8.
HoffmanJMWaiJSThomasCMLevinRBO'BrienJA & GoldmanME (1992) Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phtalimidoalkyl and alkylamino analogues. Journal of Medicinal Chemistry35: 3784–3791.
9.
HoffmanJMSmithAMRooneyCSFisherTEWaiJSThomasCMBambergerDLBarnesJLWilliamsTMJonesJHOlsonBDO'BrienJAGoldmanMENunbergJHQuinteroJCSchleifWAEminiEA & AndersonPS (1993) Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 4. 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one and analogues. Journal of Medicinal Chemistry36: 953–966.
10.
KoupRAMerluzziVJHargraveKDAdamsJGrozingerKEcknerRJ & SullivanJL (1991) Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a dipyridodiazepinone (BI-RG-587). Journal of Infectious Diseases163: 966–970.
11.
LambertJSSeidlinMReichmenRCPlankCSLavertyMMorseGDKnuppCMcLarenCPettinelliCValentineFT & DolinR (1990) 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. New England Journal of Medicine324:1412–1416.
12.
MellorsJWDurschmanGEImGJTramontanoEWinklerSR & ChengYC (1991) In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to nonnucleoside inhibitors of reverse transcriptase. Molecular Pharmacology41: 446–451.
13.
MerluzziVJHargraveKDLabadiaMGrozingerKSkoogMWuJCShihC-KEcknerKHattoxSAdamsJRosenthalASFaanesREcknerRJKoopRA & SullivanJL (1990) Inhibition of HIV-1 replication by a non-nucleoside reverse transcriptase inhibitor. Science250: 1411–1413.
14.
MitsuyaHYarchoanR & BroderS (1990) Molecular targets for AIDS therapy. Science249:1533–1544.
15.
MoogCWickAle BerPKirnA & AubertinAM (1994) Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficency virus type 1. Antiviral Research24: 275–288.
16.
MosmannT (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods65: 55–63.
17.
PaineJB (1987) A convenient synthesis of nicotinate esters from 3-cyanopyridinones. Journal of Heterocyclic Chemistry24: 351–355.
18.
PauwelsRAndriesKDesmyterJScholsDKuklaM-JBreslinHJRaeymaeckersAvan GelderJWoestenborghsRHeykantsJSchellekensHJanssenMACDe ClercqE & JanssenPAJ (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature343: 470–474.
19.
PauwelsRAndriesKDebyserZvan DaelePScholsDStaffelsPDe VreeseKWoestenborghsRVandammeA-MJanssenCGMAnnéJCauwenberghGDesmyterJHeykantsJJanssenMACDe ClercqE & JanssenPAJ (1993) Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of a-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase. Proceedings of the National Academy of Sciences, USA90: 1711–1715.
20.
RichmanDDFischlMAGriecoMHGottliebMSVolberdingPALaskinOLLeedomJMGroopmanJEMildvanDHirschMSJacksonGGDurackDTNusinoff-Lehrman S & The AZT Collaborative Working Group (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. New England Journal of Medicine317:192–197.
21.
RomeroDLBussoMTanC-KReusserFPalmerJRPoppeSMAristoffPADowneyKMSoAGResnickL & TarpleyWG (1991) Non-nucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proceedings of the National Academy of Sciences, USA88: 8806–8810.
22.
RomeroDLMorgeRAGeninMJBilesCBussoMResnickLAlthausIWReusserFThomasRC & TarpleyWG (1993) Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamide-1H-indol-2-yl)carbonyl)]-4-[3-(1-methylethyl)amino]pyridinyl piperazine monomethane-sulfonate (U-90152s). Journal of Medicinal Chemistry36:1505–1508.
23.
SaariWSHoffmanJMWaiJSFisherTERooneyCSSmithAMThomasCMGoldmanMEO'BrienJANunbergJHQuinteroJCSchleifWAEminiEASternAM & AndersonPS (1991) 2-pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors. Journal of Medicinal Chemistry34:2922–2925.
24.
SaariWSWaiJSFisherTEThomasCMHoffmanJMRooneyCSSmithAMJonesJHBambergerDLGoldmanMEO'BrienJANunbergJHQuinteroJCSchleifWAEminiEA & AndersonPS (1992) Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2 (1H)-one. Journal of Medicinal Chemistry35: 3792–3802.
25.
SaundersMHoukKNWuY-DStillW ClarkLiptonMChangG, and GuidaWC (1990) Conformations of cycloheptadecane. A comparison of methods for conformational searching. Journal of the American Chemical Society112:1419–1427.
26.
TanakaHBabaMHayakawaHSakamakiTMiyasakaTUbasawaMTakashimaHSekiyaKNittaIShigetaSWalkerRTBalzariniJ & De ClercqE (1991a) A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thyrnine (HEPT). Journal of Medicinal Chemistry34: 349–357.
27.
TanakaHBabaMUbasawaMTakashimaHSekiyaKNittaIShigetaSWalkerRTDe ClercqE & MiyasakaT (1991b) Synthesis and anti HIV activity of 2-, 3- and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). Journal of Medicinal Chemistry34:1394–1399.
28.
VinterJGDavisA & SaundersMR (1987) Strategic approaches to drug design. I. An integrated software framework for molecular modelling. Journal of Computer-Aided Molecule Design1:31.
29.
WaiJSWilliamsTMBambergerDLFisherTEHoffmanJMHudcoskyRJMacToughSCRooneyCSSaariWSThomasCMGoldmanMEO'BrienJAEminiEANunbergJHQuinteroJCSchleifWA & AndersonPS (1993) Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-(1H)-one. Journal of Medicinal Chemistry36: 249–255.
30.
YarchoanRMitsuyaHMycrsCE & BroderS (1989) Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. New England Journal of Medicine321: 726–738.
